PubMed · 14328552
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J SCHNEIDER. 1964. [PHARMACEUTICAL LEGISLATION].. https://pubmed.ncbi.nlm.nih.gov/14328552/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The following article describes the legal aspects of teleradiology in Germany. At first we analyze the general significance of teleradiology in the sense of"achieving medical service over spatial distances". Next we take a closer look at teleradiology according to the German Radiation Control Law ("Deutsche Röntgenverordnung") in the sense of primary diagnostic findings. It is obvious that, apart from the Radiation Control Law, several other laws have to be obeyed when using teleradiology. Currently all of these legal requirements concerning teleradiological service can be fulfilled by applying modern IT.
Quality of life is an important patient-relevant end point. Originally viewed with some scepticism, the concept of quality of life has now been largely accepted internationally. Numerous methodologically sound ways of measuring have become available. An ever increasing number of studies include quality of life. Also, organizations providing care are becoming more interested, but including an assessment of quality of life when researching care provisions still requires greater attention. Results of research on quality of life can contribute to assessing needs, evaluate treatment, control quality and improve health within society.
The term value denotes the effect(s) of an intervention which will improve, by more than just a little, prognosis and/or symptoms and/or quality of life of the patient. The value of a medical intervention has to be assessed in a way that the patient can be adequately informed and believable promises and pronouncements of such an intervention are made. The decisive and only relevant question when assessing value is to what extent the patient profits. The assessment of value is connected with the question about clinically or patient-relevant (i. e. relevant) end points, which for the patient means decisive and perceived events that as a rule have an effect on him/her. It is the aim of value assessment to ensure quality of an individual treatment and of medical practice in a wider sense.